Chemically modified quinoline and quinolone derivatives useful as CB-1 inverse agonists
US9815790B2 · kind B2 · utility
0Cited by
4References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 17, 2016 |
| Grant date | Nov 14, 2017 |
| Priority date | — |
| Expiry date | Aug 17, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC09B69/103
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the CB1 receptor. Such compounds are represented by Formula (I)
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.